{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T02:26:53Z","timestamp":1794536813892,"version":"4.9.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100009678","name":"Scandinavian Society for Antimicrobial Therapy","doi-asserted-by":"publisher","award":["SLS-403571"],"award-info":[{"award-number":["SLS-403571"]}],"id":[{"id":"10.13039\/100009678","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009678","name":"Scandinavian Society for Antimicrobial Therapy","doi-asserted-by":"publisher","award":["SLS-503521"],"award-info":[{"award-number":["SLS-503521"]}],"id":[{"id":"10.13039\/100009678","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Danske Regionernes Medicinpulje","award":["14\/217"],"award-info":[{"award-number":["14\/217"]}]},{"name":"Det Medicinske selskab i K\u00f8benhavn","award":["-"],"award-info":[{"award-number":["-"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12879-016-2022-0","type":"journal-article","created":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T06:58:24Z","timestamp":1480575504000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["The efficacy of pivmecillinam: 3\u00a0days or 5\u00a0days\u2009t.i.d against community acquired uncomplicated lower urinary tract infections \u2013 a randomized, double-blinded, placebo-controlled clinical trial study protocol"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0670-9996","authenticated-orcid":false,"given":"Filip","family":"Jans\u00e5ker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels","family":"Frimodt-M\u00f8ller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Bjerrum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Dahl Knudsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,12,1]]},"reference":[{"issue":"1","key":"2022_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ucl.2007.09.004","volume":"35","author":"LE Nicolle","year":"2008","unstructured":"Nicolle LE. Uncomplicated urinary tract infection in adults including uncomplicated pyelonephritis. Urol Clin North Am. 2008;35(1):1\u201312. v.","journal-title":"Urol Clin North Am"},{"issue":"5","key":"2022_CR2","doi-asserted-by":"publisher","first-page":"e103","DOI":"10.1093\/cid\/ciq257","volume":"52","author":"K Gupta","year":"2011","unstructured":"Gupta K, Hooton TM, Naber KG, Wullt B, Colgan R, Miller LG, Moran GJ, Nicolle LE, Raz R, Schaeffer AJ, et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis. 2011;52(5):e103\u2013120.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"2022_CR3","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.ijantimicag.2009.04.012","volume":"34","author":"GC Schito","year":"2009","unstructured":"Schito GC, Naber KG, Botto H, Palou J, Mazzei T, Gualco L, Marchese A. The ARESC study: an international survey on the antimicrobial resistance of pathogens involved in uncomplicated urinary tract infections. Int J Antimicrob Agents. 2009;34(5):407\u201313.","journal-title":"Int J Antimicrob Agents"},{"issue":"20","key":"2022_CR4","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.1001\/jama.287.20.2701","volume":"287","author":"S Bent","year":"2002","unstructured":"Bent S, Nallamothu BK, Simel DL, Fihn SD, Saint S. DOes this woman have an acute uncomplicated urinary tract infection? JAMA. 2002;287(20):2701\u201310.","journal-title":"JAMA"},{"key":"2022_CR5","unstructured":"Antibiotikavejledning 2016. Dansk L\u00e6gemiddel Information A\/S. http:\/\/pro.medicin.dk\/Specielleemner\/Emner\/318565 Accessed 5 Aug 2016."},{"issue":"Suppl 1","key":"2022_CR6","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1093\/jac\/46.suppl_1.35","volume":"46","author":"LE Nicolle","year":"2000","unstructured":"Nicolle LE. Pivmecillinam in the treatment of urinary tract infections. J Antimicrob Chemother. 2000;46 Suppl 1:35\u20139. discussion 63\u201335.","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl 1","key":"2022_CR7","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1093\/jac\/46.suppl_1.49","volume":"46","author":"KG Naber","year":"2000","unstructured":"Naber KG. Survey on antibiotic usage in the treatment of urinary tract infections. J Antimicrob Chemother. 2000;46 Suppl 1:49\u201352. discussion 63\u201345.","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl 2","key":"2022_CR8","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0924-8579(03)00235-8","volume":"22","author":"W Graninger","year":"2003","unstructured":"Graninger W. Pivmecillinam--therapy of choice for lower urinary tract infection. Int J Antimicrob Agents. 2003;22 Suppl 2:73\u20138.","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"2022_CR9","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ijantimicag.2011.09.013","volume":"39","author":"G Kahlmeter","year":"2012","unstructured":"Kahlmeter G, Poulsen HO. Antimicrobial susceptibility of Escherichia coli from community-acquired urinary tract infections in Europe: the ECO.SENS study revisited. Int J Antimicrob Agents. 2012;39(1):45\u201351.","journal-title":"Int J Antimicrob Agents"},{"key":"2022_CR10","volume-title":"Use of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from food animals, food and humans in Denmark","author":"DANMAP","year":"2014","unstructured":"DANMAP. Use of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from food animals, food and humans in Denmark. 2014. ISSN 1600\u20132032."},{"issue":"9","key":"2022_CR11","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1093\/jac\/dkt159","volume":"68","author":"HO Poulsen","year":"2013","unstructured":"Poulsen HO, Johansson A, Granholm S, Kahlmeter G, Sundqvist M. High genetic diversity of nitrofurantoin- or mecillinam-resistant Escherichia coli indicates low propensity for clonal spread. J Antimicrob Chemother. 2013;68(9):1974\u20137.","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"2022_CR12","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1080\/02813430601183074","volume":"25","author":"SA Ferry","year":"2007","unstructured":"Ferry SA, Holm SE, Stenlund H, Lundholm R, Monsen TJ. Clinical and bacteriological outcome of different doses and duration of pivmecillinam compared with placebo therapy of uncomplicated lower urinary tract infection in women: the LUTIW project. Scand J Prim Health Care. 2007;25(1):49\u201357.","journal-title":"Scand J Prim Health Care"},{"issue":"3","key":"2022_CR13","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1093\/jac\/dkt404","volume":"69","author":"F Jansaker","year":"2014","unstructured":"Jansaker F, Frimodt-Moller N, Sjogren I, Dahl Knudsen J. Clinical and bacteriological effects of pivmecillinam for ESBL-producing Escherichia coli or Klebsiella pneumoniae in urinary tract infections. J Antimicrob Chemother. 2014;69(3):769\u201372.","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"2022_CR14","doi-asserted-by":"publisher","first-page":"e85889","DOI":"10.1371\/journal.pone.0085889","volume":"9","author":"A Soraas","year":"2014","unstructured":"Soraas A, Sundsfjord A, Jorgensen SB, Liestol K, Jenum PA. High rate of Per oral mecillinam treatment failure in community-acquired urinary tract infections caused by ESBL-producing Escherichia coli. PLoS One. 2014;9(1):e85889.","journal-title":"PLoS One"},{"key":"2022_CR15","unstructured":"Jensen KS, Henriksen AS, Frimodt-Moeller N (2008) Pivmecillinam: estimation of adequate dosage for susceptible and ESBL-producing E. coli by Monte Carlo PK\/PD simulation. Abstracts of the 18nd European Congress of Clinical Microbiology and Infectious Diseases, Barcelona, Spain, 2008 Abstract P1255 European Society of Clinical Microbiology and Infectious Diseases, Basel, Switzerland"},{"issue":"3","key":"2022_CR16","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1111\/j.1464-410X.2005.05630.x","volume":"96","author":"D Clayson","year":"2005","unstructured":"Clayson D, Wild D, Doll H, Keating K, Gondek K. Validation of a patient-administered questionnaire to measure the severity and bothersomeness of lower urinary tract symptoms in uncomplicated urinary tract infection (UTI): the UTI Symptom Assessment questionnaire. BJU Int. 2005;96(3):350\u20139.","journal-title":"BJU Int"},{"key":"2022_CR17","volume-title":"R: A language and environment for statistical computing","author":"R Core Team","year":"2015","unstructured":"Core Team R. R: A language and environment for statistical computing. Austria: R Foundation for Statistical Computing V; 2015. https:\/\/www.R-project.org\/ ."},{"key":"2022_CR18","volume-title":"Breakpoint tables for interpretation of MICs and zone diameters - Version 3.1","author":"The European Committee on Antimicrobial Susceptibility Testing","year":"2013","unstructured":"The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters - Version 3.1. Sweden: EUCAST V; 2013. http:\/\/www.eucast.org ."},{"issue":"3","key":"2022_CR19","doi-asserted-by":"publisher","first-page":"e1000251","DOI":"10.1371\/journal.pmed.1000251","volume":"7","author":"KF Schulz","year":"2010","unstructured":"Schulz KF, Altman DG, Moher D, Group C. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. PLoS Med. 2010;7(3):e1000251.","journal-title":"PLoS Med"},{"key":"2022_CR20","doi-asserted-by":"crossref","unstructured":"Dewar S, Reed LC, Koerner RJ: Emerging clinical role of pivmecillinam in the treatment of urinary tract infection in the context of multidrug-resistant bacteria. J Antimicrob Chemother. 2013.","DOI":"10.1093\/jac\/dkt368"},{"issue":"2","key":"2022_CR21","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/S1473-3099(01)00066-4","volume":"1","author":"A Sullivan","year":"2001","unstructured":"Sullivan A, Edlund C, Nord CE. Effect of antimicrobial agents on the ecological balance of human microflora. Lancet Infect Dis. 2001;1(2):101\u201314.","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"2022_CR22","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1080\/02813430802535312","volume":"27","author":"L Bjerrum","year":"2009","unstructured":"Bjerrum L, Gahrn-Hansen B, Grinsted P. Pivmecillinam versus sulfamethizole for short-term treatment of uncomplicated acute cystitis in general practice: a randomized controlled trial. Scand J Prim Health Care. 2009;27(1):6\u201311.","journal-title":"Scand J Prim Health Care"},{"issue":"2","key":"2022_CR23","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1089\/mdr.2011.0161","volume":"18","author":"E Titelman","year":"2012","unstructured":"Titelman E, Iversen A, Kalin M, Giske CG. Efficacy of pivmecillinam for treatment of lower urinary tract infection caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae. Microb Drug Resist (Larchmont, NY). 2012;18(2):189\u201392.","journal-title":"Microb Drug Resist (Larchmont, NY)"},{"key":"2022_CR24","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1186\/s12879-014-0693-y","volume":"14","author":"I Vik","year":"2014","unstructured":"Vik I, Bollestad M, Grude N, Baerheim A, Molstad S, Bjerrum L, Lindbaek M. Ibuprofen versus mecillinam for uncomplicated cystitis--a randomized controlled trial study protocol. BMC Infect Dis. 2014;14:693.","journal-title":"BMC Infect Dis"},{"key":"2022_CR25","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/1471-2334-12-146","volume":"12","author":"I Gagyor","year":"2012","unstructured":"Gagyor I, Hummers-Pradier E, Kochen MM, Schmiemann G, Wegscheider K, Bleidorn J. Immediate versus conditional treatment of uncomplicated urinary tract infection - a randomized-controlled comparative effectiveness study in general practices. BMC Infect Dis. 2012;12:146.","journal-title":"BMC Infect Dis"},{"issue":"7","key":"2022_CR26","first-page":"771","volume":"84","author":"R Colgan","year":"2011","unstructured":"Colgan R, Williams M. Diagnosis and treatment of acute uncomplicated cystitis. Am Fam Physician. 2011;84(7):771\u20136.","journal-title":"Am Fam Physician"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-016-2022-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-016-2022-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-016-2022-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,16]],"date-time":"2019-09-16T00:36:14Z","timestamp":1568594174000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-016-2022-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["2022"],"URL":"https:\/\/doi.org\/10.1186\/s12879-016-2022-0","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12]]},"article-number":"727"}}